Archiv verlassen und diese Seite im Standarddesign anzeigen : UPS und DOWNS bei den AMI-Werten!
Seiten :
1
2
3
4
5
6
[
7]
8
9
10
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
Google kommt nicht so recht aus dem Seitwärtstrend heraus - 455 T und 513 Hoch, dort liegt der Deckel!
20.02.2007 19:45
Bekommt Google Konkurrenz?
von Jochen Steffens
Ein paar Tage ausspannen, etwas das nie falsch sein kann. Und doch habe ich immer wieder das Gefühl, es schießt einen geradezu aus dem Börsenuniversum, wenn man nicht jeden Tag 100 % dabei ist. Und eins ist sicher: Je länger man der Börse fern geblieben ist, desto länger braucht man auch, um wieder einzusteigen.
Da gestern in den USA Feiertag war, wird auch die weitere Richtung erst heute entschieden, zumal am Freitag kleiner Verfallstag war. Morgen wird dann auch noch das Fed-Protokoll veröffentlicht, das dem Markt weitere Impulse geben sollte. Etwas längerfristig betrachtet, wird es dem Markt in den nächsten Wochen darum gehen, ob wieder Zinssenkungsphantasie aufkommt.
Das kann durch schlechtere Konjunkturdaten geschehen, sollte aber unbedingt durch einen fallenden oder zumindest gleichbleibenden Ölpreis untermauert werden.
Soweit zu den groben Faktoren, die den Markt in den nächsten Tagen bis Wochen beeinflussen werden. Bis die Amis aber wieder den Takt vorgeben, bleibt etwas Zeit, über ein anderes höchst spannendes Thema zu schreiben.
Eine der besten Suchmaschinen
Ich kann mich noch daran erinnern, dass mich eine Bekannte vor Jahren auf die Suchmaschine Google (Nachrichten/Aktienkurs) hingewiesen hat. Und tatsächlich, Google war besser. Das hat zwar mittlerweile meines Erachtens etwas nachgelassen, aber Google ist immer noch die Suchmaschine mit den meisten Nutzern. Dagegen konnte selbst Microsoft nichts machen und musste sämtliche Ambitionen, eine Konkurrenz zu Google aufzubauen, aufgeben.
Jetzt könnte Google aber doch Konkurrenz bekommen; aus einer Ecke, der ich zum ersten Mal wirklich zutraue, Google vom Thron zu stürzen. Wobei ich ehrlich bin, ich hatte die Hoffnung schon fast aufgegeben, dass es einmal dazu kommen wird.
Wikipedia will nun eine eigene Suchmaschine etablieren. Es seien bereits einige namhafte Investoren interessiert. Gut, das allein reicht natürlich nicht, Suchmaschinen gibt es viele. Es ist die Idee, die dahinter steht, und die auch schon Wikipedia zu einem unglaublichen Internetnachschlagewerk gemacht hat.
Der Mensch beurteilt besser als der Computer
So soll bei Wiki Search auch kein Algorithmus die Suchergebnisse bestimmen, sondern der Mensch selbst. Die Nutzer sollen bewerten und ordnen, so hört man.
Würde das funktionieren, dann könnte das tatsächlich zu einer wichtigen Revolution auf dem Suchmaschinenmarkt werden. Schließlich ist es tatsächlich kein unbedingtes Qualitätsmerkmal mehr, die Webseiten nach Verweisen zu sortieren. Mittlerweile haben sich zu viele Anbieter darauf eingestellt und versuchen mit allen möglichen Tricks, sich bei bestimmten Suchworten weit nach vorne zu bringen.
Würde jedoch eine menschliche Bewertung die Seiten beurteilen, und das in der Masse, würde eine wesentlich objektivere Sortierung der Ergebnisse möglich sein. Somit wäre es auch wesentlich schwieriger, hier Ergebnisse zu fälschen beziehungsweise zu beeinflussen.
Die Umsetzung ist kaum möglich?
Allerdings weiß ich noch nicht, wie das umgesetzt werden soll. Wer will schon bei seiner Suche im Internet beständig alle Seiten, die er findet, bewerten? Zudem gibt es Millionen verschiedener Seiten im Internet. Hier würde eine Kontrolle und Bewertung extrem schwer. Ich kann mir noch nicht vorstellen, wie das im Detail funktionieren soll, ich habe mich damit aber natürlich auch noch nicht auseinander gesetzt. Man muss dem Mitgründer der Online-Enzyklopädie Jimmy Wales eins lassen: An Wikipedia hat auch zunächst keiner geglaubt. Also ich werde mich überraschen lassen.
Da ich keine Monopolisierungen mag, bin ich der Auffassung, dass es dem Internet gut täte, wenn Google eine ernst zunehmende Konkurrenz erhält. Und so wie ich damals schon recht früh zu Google gewechselt bin, würde ich auch ebenso schnell zu Wiki Search wechseln wenn es sich lohnt.
Was das für die Aktie von Google bedeuten würde, kann man sich vorstellen. Nein, nicht wenn ich zu Wiki Search wechsle, sondern wenn Wiki Search es tatsächlich schaffen würde, Google größere Marktanteile abzuluchsen. Sobald sich das abzeichnet, wäre es ein guter Zeitpunkt, Google zu shorten. Aber, wie gesagt, dazu muss erst einmal abgewartet werden, was schlussendlich aus dieser Idee wird und ob sie sich tatsächlich als alltagstauglich erweist.
20. Februar 2007, 08:43
Hat Google GoYellow im Visier?
(chs) Google zeigt offenbar Interesse an einer Übernahme des deutschen Auskunftsportals GoYellow. Das Unternehmen ist auf die lokale Suche nach Firmen, Geschäften und Adressen spezialisiert.
Hintergrund des Interesses scheint aber eine Nebentätigkeit zu sein. GoYellow zeichnet Geschäfte und Restaurants seiner Inserenten in Stadtpläne ein, die mit Luftbildern versehen sind. Die dafür benötigten Daten bezieht das Unternehmen vom Schweizer Anbieter Endoxon, den Google im Dezember 2006 übernommen hat. GoYellow besitzt bis Ende 2009 die alleinigen Nutzungsrechte für die Deutschland-Luftbilder, was das Interesse von Google erklären könnte.
Quellen: Die Welt, FINANCE
JetBlue Airways Corporation
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=JBLU.NAS&lColors=0x000000&sSym=JBLU.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=JBLU.NAS&lColors=0x000000&sSym=JBLU.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=JBLU.NAS&lColors=0x000000&sSym=JBLU.NAS&hcmask=
Bei solchen News kommen dann solche Folgen:rolleyes::rolleyes::rolleyes:
JetBlue's woes spawn 'customer bill of rights'
Feb 20, 2007 (Newsday - McClatchy-Tribune Business News via COMTEX) -- After six of the most wrenching days in its history, JetBlue Airways Corp. said yesterday it plans to unveil today a "customer bill of rights" that is to detail what the low-cost airline will do to help out passengers in the event of another storm such as the one that has crippled service since Wednesday.
Forest Hills-based JetBlue said it is on the road to straightening out its schedule after hundreds of flights were canceled after the Valentine's Day storm. But early yesterday morning, the airline said it canceled an additional 139 flights. JetBlue had originally scheduled 600 flights for Presidents Day, more than the 550 to 575 flights scheduled for a typical Monday.
Alison Eshelman, a JetBlue spokeswoman, said the airline will announce details of its "customer bill of rights" early today.
"It's going to detail what customers can expect of JetBlue," Eshelman said. "We're going to include what penalties we will assume as well as what passengers can expect from us."
She said JetBlue Chairman and Chief Executive David Neeleman and top airline executives are working on the document.
"It's going to be more meaningful, broader and deeper than anything in the industry today and it's going to restore the faith of our customers," Eshelman said. She declined to disclose any other details.
A report in yesterday's New York Times described an emotional Neeleman saying he is "humiliated and mortified" by the breakdown in the operations of the 6-year-old airline, which had been highly popular among customers. Neeleman said in the interview that in the future JetBlue will pay penalties to customers if they are stranded on a plane for too long.
Neeleman said the part of the company that coordinates flight assignments for pilots and flight attendants is not large enough and that 100 existing employees will be trained to work in that area when needed.
Yesterday, all JetBlue flights were canceled out of 11 airports: Richmond, Va; Pittsburgh; Charlotte and Raleigh-Durham, N.C; Jacksonville, Fla; Austin and Houston in Texas; Columbus, Ohio; Nashville, Tenn; Portland, Maine; and Bermuda.
Meanwhile, airlines in general are again trying to head off congressional regulation that would govern what carriers must do in the event of lengthy delays.
Sen. Barbara Boxer (D-Calif.) has said she intends to propose a bill giving passengers the right to get off planes after a set amount of time. A group called the Coalition for an Airline Passengers' Bill of Rights wants a mandatory three-hour cap on wait times as part of an 11-point list of requirements, including adequate food and water, and working toilets.
The Air Transport Association, a Washington, D.C.-based group representing major airlines, opposes such legislation. David Castelveter, a spokesman for the association, said if a flight had to return to a gate after, say, three hours, but could take off in another 15 minutes, "it creates a true hardship for passengers."
SULPHCO INC
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=
Sie braucht eine ordentliche Konsolidierung!!
SulphCo(R) Provides Status Report on Probes
SPARKS, Nev., Feb 13, 2007 /PRNewswire-FirstCall via COMTEX/ -- SulphCo(R), Inc. (Amex: SUF) announced today an update on the improvement and shipping status of the probes.
Four probes were recently tested and successfully passed screening tests in Sparks, Nevada in preparation for shipment to NTG. The probes were sent on February 7th to NTG to start the protocol for pressure and wet testing of the skid to be sent to Austria. It is expected that the preparation will take two to three weeks. Two SulphCo(R) engineers are at NTG this week to oversee the probe wiring, installation, and testing.
Dr. Larry Ryan, CEO of SulphCo(R) stated, "I am pleased to announce the status of the probes and to further validate our efforts to remain transparent with our shareholders. We are continuing to work with our external probe vendors and are receiving and testing prototype probes on a weekly basis. It is imperative that we continue to perfect the probes as we draw nearer to running them in the first large scale test application."
Currently, no probes have been shipped to Fujairah; however a SulphCo(R) team is in Fujairah this week and will return with an update.
About SulphCo(R), Inc.
SulphCo(R) has developed a patented safe and economic process employing ultrasound technology to desulfurize and hydrogenate crude oil and other oil related products. The Company's technology upgrades sour heavy crude oils into sweeter, lighter crudes, producing more gallons of usable oil per barrel.
Overstock.com, Inc.
20.02.07 22:00 Uhr
19,03 USD
+4,33 % [+0,79
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=OSTK.NAS&lColors=0x000000&sSym=OSTK.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=OSTK.NAS&lColors=0x000000&sSym=OSTK.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=OSTK.NAS&lColors=0x000000&sSym=OSTK.NAS&hcmask=
Es schreit direkt nach Konsolidierung.
Sonus Networks, Inc
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SONS.NAS&lColors=0x000000&sSym=SONS.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SONS.NAS&lColors=0x000000&sSym=SONS.NAS&hcmask=
Schöner Aufwärtstrend! Überkauft-Signal total abgebaut. Widerstand bei 8,00.
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SONS.NAS&lColors=0x000000&sSym=SONS.NAS&hcmask=
Der Staat, die Airlines und die Lobby
Wer den Schaden hat, braucht für den Spott nicht zu sorgen. Der Billig- und Überflieger JetBlue ist wegen Schnee, Eis und Miss-Management zum Gespött an der Wall Street und im Late-Night-TV geworden. Doch das Schlimmste: Man muss den Millionen-Schaden selbst tragen, kann sich nicht auf weitere Hilfe der Regierung verlassen.
Das ist ungewöhnlich für die sonst so verwöhnte Airline-Branche, denn in den letzten Jahren hatte es sich geradezu eingebürgert, dass die Regierung angeschlagenen Unternehmen zur Seite sprang. Der Grund: Die Branche war direkt nach und auch wegen der Terror-Anschläge auf das World Trade Center am 11. September 2001 in Schwierigkeiten geraten die Folgen einer nationalen Katastrophe wollte Uncle Sam nicht den Unternehmen selbst aufbürden.
Doch war die Branchenkrise, die zahlreiche Traditions-Carrier an den Rand oder in den Ruin trieb, nur teilweise von 9/11 bedingt. Die Katastrophe kostete American und United Airlines nicht nur jeweils zwei Flugzeuge, zahlreiche Mitarbeiter und sorgte für ein schwer zu bewältigendes Trauma. Sie verdarb dem halben Land auch zunächst einmal die Lust aufŽs Fliegen die Buchungen nahmen rapide ab.
Doch auch der steigenden Ölpreis und damit immer teureres Flugbenzin erschwerten den Unternehmen die Geschäfte. Ebenso die unflexiblen Verträge mit Piloten, Besatzung und Bodenpersonal. Dazu kamen der schlechte Service an Bord und weitere Management-Pannen, wie ein Millionen-Bonus, den sich der damalige AMR-Boss Don Carty genehmigte, kaum dass er die Gehälter der Mitarbeiter erfolgreich gedrückt hatte. Alles in allem gelang der Branche in den letzten Jahren nicht allzuviel, doch nicht alles konnte man auf 9/11 schieben.
Die Regierung sprang den Unternehmen dennoch zur Seite und gab in den letzten Jahren eine Finanzspritze von mehr als 15 Milliarden Dollar. Ob das sinnvoll war, ist unter Experten und Wählern! noch immer umstritten. Doch ein kleiner Passus, den die Autoren des damaligen Airline-Unterstützungs-Gesetzes in die Vorlage aufnahmen, lässt den Staat zumindest zum Teil an der Erholung der Branche teilhaben.
Jon Corzine, Demokrat aus New Jersey, und Peter Fitzgerald, Republikaner aus Illinois, die Autoren des Gesetzes, haben beide Erfahrung im Finanzsektor: Corzine als ehemaliger CEO von Goldman Sachs und Fitzgerald als Berater einer Privatbank. Die beiden sorgten dafür, dass die unterstützten Airlines Uncle Sam Optionen überschreiben mussten. Kauf und Verkauf der entsprechenden Papiere für Frontier und America West haben bisher 119 Millionen Dollar in die Staatskasse gebracht, weitere 130 Millionen Dollar liegen in Papieren von World Airways.
Stellt sich die Frage: Warum wird Uncle Sam nicht regelmäßig für Zahlungen an Unternehmen mit Optionen bedacht? Immerhin hat sich das System schon in der Vergangenheit ausgezahlt. Als die Regierung 1979 Chrysler aus der Klemme half, bekam man Optionen, die später 300 Millionen Dollar einbrachten. Schießt der Staat hingegen 21 Millionen Dollar in die HIV-Forschung, wie neulich beim Pharmazeuten Argos geschehen, ist von einer Beteiligung nirgends die Rede nicht einmal, wenn die staatlich finanzierte Forschung zu Rekordgewinnen für das Unternehmen führt.
Nun, warum lässt sich Uncle Sam nicht regelmäßig am Unternehmenserfolg beteiligen? Laut Experten in Washington fehlt es nicht an Ideen und Gelegenheit. Vielmehr scheinen die mächtigen Lobbyisten den Politikern regelmäßig solche Spielchen auszureden. Die Unternehmen wollen im Erfolgsfall alleine kassieren, und dank großzügiger Wahlkampfspenden haben sie genug Macht, das auch durchzubringen.
Im Falle der Airline-Branche hatte Uncle Sam letztlich auch nur Glück. Gesetzes-Autor Fitzgerald, der 2005 seinen Seatsposten aufgegeben hat, erinnert sich: Die Fluggesellschaften waren so unorganisiert, sie konnten sich selbst nicht einigen, was für sie am besten wäre. Von diesem Miss-Management profitierte der Staat.
Lars Halter
GRACE W R CO NEW %)
Sedol: 2232685 Exch: NYSE Sym: GRA.NYS
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GRA.NYS&lColors=0x000000&sSym=GRA.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=GRA.NYS&lColors=0x000000&sSym=GRA.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GRA.NYS&lColors=0x000000&sSym=GRA.NYS&hcmask=
Der Deckel muß erst weg, bevor es wieder hochgehen kann.
Börse
NYSE
Aktuell
25,75 USD
Zeit
21.02.07 22:02
Diff. Vortag
+5,40 %
Tages-Vol.
30,73 Mio.
Gehandelte Stück
1,2 Mio.
bellwetherreport.com: Shareholder Alert for W. R. Grace & Co.
Feb 07, 2007 (M2 PRESSWIRE via COMTEX) -- W. R. Grace & Co. has embraced Thoreau's call to simplify. The company has restructured from six product groups into two major units, each accounting for about half of sales. Grace's Davison Chemicals unit makes silica-based products, chemical catalysts, and refining catalysts that help produce refined products from crude oil. Its Performance Chemicals unit makes concrete and cement additives, packaging sealants, and fireproofing chemicals. The company's customers include chemicals companies, oil refiners, and construction firms. Grace filed for bankruptcy protection in 2001 after an unexpected increase in asbestos litigation (injury claims nearly doubled in 2000); the company no longer makes such products.
Shares were down 3% swings to a fourth quarter profit.
Sirius Satellite Radio Inc.
21.02.07 22:00 Uhr
3,92 USD
+0,00 % [+0,00]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
Börse
NASDAQ
Aktuell
3,92 USD
Zeit
21.02.07 22:00
Diff. Vortag
+0,00 %
Tages-Vol.
429,65 Mio.
Gehandelte Stück
114 Mio
Sales of satellite radio receivers remain steady
Feb 21, 2007 (Post-Bulletin - McClatchy-Tribune Business News via COMTEX) -- What kind of reception is a proposed merger between the two satellite radio providers picking up from Rochester music and sports fans?
Sirius Satellite Radio and XM Satellite Radio announced the plan earlier this week, and it doesn't seem to have hurt sales of each company's equipment.
Sales of both are still steady, says Rochester Best Buy sales representative Mike Conard. Neither one seems more popular than the other.
"Both are very, very competitive," he says.
The companies do not release subscriber numbers for specific areas such as Rochester or Minnesota.
The main differences between the two is XM's focus on music along with Oprah Winfrey, Bob Dylan and major league baseball while Sirius has an edge in the sports area with pro football and racing, along with Howard Stern.
Sports is why Greg Nicholay of Rochester subscribes to Sirius, which he listens to in his car.
"The reason I went out and got it was that I could listen to all of the NFL games," he said. "And I'm a graduate of the Naval Academy, and they carry all the Navy games.
However the merger plays out, Nicholay wants to keep listening.
"I use it a lot," he said. " Hopefully down the road ... in my next car, I'd have it installed."
XM previously carried NASCAR races, but Sirius picked that up in January. Now that race season is in full swing, listeners are really noticing.
"Lately, I've had a lot people coming in who had XM to listen to NASCAR saying, 'Switch me to Sirius,'" Conard said.
The proposed merger, however, has clouded the issue of which company offers which -- sports or music.
"Some people are buying (equipment) because they say it will be lumped together," Conard said. "They say it won't matter (which system you choose) eventually."
XM radio receivers can't receive signals from Sirius and vice versa. The companies are working on developing a receiver that could receive both signals.
In the meantime, they said, assuming the deal goes through, the companies would make other arrangements to provide programming that's currently exclusive to one provider to listeners of the other, such as getting Major League Baseball games -- currently only available on XM -- to Sirius listeners.
By Jeff Kiger
Google: (K)ein Angriff auf Microsoft
Seit Google in einer beeindruckenden Zwei-Jahres-Rallye den Aktienkurs von 80 auf über 500 Dollar gesteigert hat, hatte es die Suchmaschine zunehmend schwer, sich als harmloser Internet-Wert dazustellen. Ab sofort ist das gar nicht mehr möglich, denn mit einem Frontalangriff auf Microsoft zeigt das Unternehmen Zähne.
Dabei hatte Google-CEO Eric Schmidt in den letzten Monaten wiederholt beteuert, dass Google keineswegs in Konkurrenz zu Microsoft treten wolle. Analysten hatten das immer wieder vermutet. Immerhin hat die Suchmaschine immer mehr Internet-basierte Software aufgenommen, die User zumindest theoretisch dazu hätten bewegen können, Windows den Rücken zu kehren.
Doch das kostenlose Textverarbeitungsprogramm, das nun den Namen Google Docs trägt, sollte nicht Windows ersetzen, so Schmidt. Und die Tabellenkalkulation, die nun Google Spreadsheet heißt, auch nicht Excel. Doch seit beide Programm und noch einige mehr, darunter ein Email-Server, ein Kalenderdienst, zehn Gigabyte Speicher und eine Telefon-Hotline für den Kundendienst, am Donnerstag für 50 Dollar pro Jahr und Kunde im Profi-Pack erhältlich sind, lässt sich kaum mehr leugnen, dass sich Google an Bill GatesŽ Software-Riesen orientiert.
Bei Microsoft muss man sich deswegen nicht fürchten. Es ist kaum anzunehmen, dass Google mit seinen Internet-Programm einen auch nur spürbaren Bissen aus dem Windows-Kuchen beißen wird. Rund 450 Millionen User weltweit arbeiten immerhin mit den Office-Programmen, während die Geschäftssparte von Google gerade einmal 100 000 Kunden für das bisher kostenlose Paket hatte.
Selbst wenn alle 100 000 Kunden kostenpflichtig zu Google wechseln würden, wäre das kein Verlust für Microsoft. Und für Google zunächst kein großer Gewinn, denn die 5 Millionen Dollar Umsatz, die das einspielen würde, sind gemessen am Gesamtumsatz des Konzerns von zuletzt 10,6 Milliarden Dollar in 2006 geradezu verschwindend gering.
Dass die Aktie von Google dank der Pro-Apps am Donnerstag dennoch ins Plus kletterte, ist den Aussichten zu verdanken, die Anleger in bezug auf die Geschäftspolitik des Unternehmens haben. Dass der konsequente Wechsel von Microsoft- auf Google-Programme einem Unternehmen pro Lizenz gute 600 Dollar jährlich sparen könnte, ist nämlich nur in zweiter Linie für Großkunden interessant. Vielmehr aber öffnet das neue Service-Paket den kleinen und mittleren Betrieben Türen, die bislang gar nicht im Internet vertreten waren.
Um diesen Markt um die Restaurants, Schuhverkäufer, Schreibwarenläden und Massage-Salons kämpft Google schon seit Jahren, unter anderem in komplett anzeigen-unterstützten Programmen wie Google Earth. Der Erfolg war bisher bescheiden: Bis heute hat etwa die Hälfte der amerikanischen Arbeitsnehmer keinen Email-Anschluss in Büro oder Betrieb. Hier liegt Wachstumspotenzial, das Microsoft und andere Anbieter bisher vernachlässigt haben.
Googles neues Paket ist also ein Knüller nicht so sehr in bezug auf die aktuelle Gestalt des Angebots. Vielmehr ist die Google Apps Premier Edition ein weiterer Indikator für die visionäre Geschäftsführung im Googleplex und die ist, worauf Anleger mit jeder gekauften Aktie setzen.
Lars Halter
Ahead of the Bell: Merck Up on Upgrade
Monday February 26, 9:11 am ET
Merck Upgraded to "Buy" at Citigroup Based on Diabetes and Cervical Cancer Drug Sales
NEW YORK (AP) -- A Citigroup analyst upgraded shares of drug maker Merck & Co. Inc. to "Buy" before the start of trading Monday, predicting strong sales of its type II diabetes drug Januvia.
Analyst George Grofik increased his sales predictions for Januvia, and raised his target price to $50 per share from $45. Grofik said his research shows physicians expect to prescribe Januvia for 10 percent of their patients within a year.
Grofik also forecast solid sales for Gardasil, a cervical cancer vaccine.
"While adoption in mandatory state vaccination programs is critical for the product's uptake, we also see an interesting upside opportunity in mid-adult women," he said.
Whitehouse Station, N.J.-based Merck is also keeping its expenses down, he said.
Merck shares gained $1.47, or 3.4 percent, to $44.41 in premarket electronic trading, from their close at $42.94 Friday on the New York Stock Exchange.
Übernahmegerüchte treiben AMD-Aktie in die Höhe
Di Feb 27, 2007 7:22 MEZ
New York (Reuters) - Übernahmespekulationen haben am Montag die Aktien des US-Chipkonzerns AMD um mehr als fünf Prozent in die Höhe getrieben.
Am Markt kursierten Gerüchte, Beteiligungsgesellschaften hätten Interesse an AMD, sagte Paul Foster vom Web-Informationsdienst theflyonthewall.com. Die Gerüchte seien aber nicht bestätigt. Ein AMD-Sprecher lehnte einen Kommentar dazu ab. Das AMD-Handelsvolumen für im März fällige Optionen sei ungewöhnlich hoch, sagte auch Steve Sosnick von Timber Hill. Zumindest kurzfristig schenke der Markt den Gerüchten über eine Übernahme Glauben.
AMD ist der weltweit zweitgrößten Chiphersteller nach Intel und beschäftigt in Deutschland mehr als 3000 Mitarbeiter - vor allem in seinen Chipfabriken in Dresden.
Ahead of the Bell: Sherwin-Williams
Tuesday February 27, 9:10 am ET
Market Overreacted to Ruling That Could Force Sherwin-Williams to Remove Lead Paint - Analyst
NEW YORK (AP) -- The market overreacted when it batted down Sherwin-Williams Co.'s stock Monday after a judge's ruling made it more likely the paint maker would have to pay to clean up lead paint in Rhode Island, a KeyBanc analyst wrote in a research report.
ANZEIGE
A Providence Superior Court judge on Monday denied Sherwin-Williams' request to revisit a jury's ruling finding the company liable for lead contamination in paint. The judge, Michael Silverstein, affirmed the jury's ruling and said he will appoint an adviser to help decide how to force Sherwin-Williams and two other paint makers to clean the lead.
While paint manufacturers stopped making paint with lead almost 30 years ago, lead-contaminated paint is still in 250,000 older homes in the state. Lawyers for the state estimated the cleanup could cost more than $1 billion.
But KeyBanc Capital Markets analyst Saul H. Ludwig said that's only if the companies strip the paint out of all 250,000 homes. That won't be necessary, he said. There's a process called lead safe, which means managing the lead contamination rather than removing the paint entirely.
The lead safe process would cost less than $20 million to implement in Rhode Island, he said. Based in Cleveland, Sherwin-Williams operates more than 3,000 stores and booked $7.81 billion sales last year.
Plus, Sherwin-Williams can appeal Silverstein's ruling to the state Supreme Court, which would take at least a year and a half.
"It will be quite some time before all appeals are exhausted, and it remains uncertain as to how much, if any, liability Sherwin-Williams will bear," Ludwig said.
Ludwig said the 3.2 percent drop in Sherwin-Williams' stock Monday was "an inappropriate but not surprising overreaction by the market."
Sherwin-Williams shares closed at $67.77 on the New York Stock Exchange Monday.
Dallas-based NL Industries Inc., and Millennium Holdings LLC, owned by Lyondell Chemical Co., are co-defendents in the suit.
Tenet Healthcare 4Q Losses $386 Million Vs $286 Million2-27-07 8:59 AM EST |
DOW JONES NEWSWIRES
Tenet Healthcare Corp. (THC) said Tuesday its fourth-quarter loss widened to $ 386 million, or 82 cents a share, from a loss of $286 million, or 61 cents, a year earlier.
The average estimated loss of 18 analysts surveyed by Thomson Financial was 4 cents a share.
The Dallas company said revenue for the three months ended Dec. 31 rose 2.6% to $2.18 billion from $2.12 billion.
-Thomas Middleton; 415-439-6400
Wall Street News Alert: UCPI Is on the Move! February 27, 2007 NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
WESTON, FL, Feb 27, 2007 (MARKET WIRE via COMTEX) -- Wall Street News Alert's "stocks to watch" this morning are:
Unicorp, Inc. (OTCBB: UCPI),
Chesapeake Energy Corporation (NYSE: CHK),
TXU Corp. (NYSE: TXU) and
Evergreen Solar, Inc. (NASDAQ: ESLR)
News just released by Unicorp Inc., (OTCBB: UCPI), may get the attention of investors this morning. Yesterday after the markets closed, the company (engaged in the acquisition, development, exploration and production of crude oil and natural gas) issued a press release announcing that the drilling of its South Creole Prospect located in Cameron Parish, Louisiana has been completed and that electric logs indicate approximately 35 feet of pay.
This could be a big deal for the company! Operations to complete the well will begin within the next several weeks and when brought online will double Unicorp's existing revenue. The South Creole Prospect was drilled to a depth of approximately 11,300 feet to test the Planulina A formation. Total reserves are estimated to be 2.5 Bcf of natural gas with associated condensate production. Unicorp has a 28.3% working interest and approximately a 21% net revenue interest in the well.
"This is a good find for our company and will significantly enhance our revenue," stated Kevan Casey, CEO of Unicorp. "We hope to have this well completed and producing during our next fiscal quarter."
Unicorp is not just your average "prospecting" company. The company actually has oil-producing wells. The Walley Estate #1 has been producing an average of approximately 85 barrels of oil per day and has produced over $200,000 in gross oil revenue since first production in November 2006. Unicorp has a 60% working interest and a 47.55% net revenue interest in this prospect.
The company recently announced its participation in the North Cayuga Prospect located in Henderson County, Texas. This prospect has the potential for eight wells and potential gross reserves of 1,000,000 barrels of oil and 4 Bcf of gas. Unicorp will have a 21% working interest and an approximate 16% working interest after payout in this prospect.
Wall Street News Alert is continuing to alert investors to monitor the progress of Unicorp as the company continues to release positive news. Near the end of last year, the company announced that it expected to triple its gross profit in fiscal 2007 to approximately $3,000,000 versus 2006 of approximately $760,000 and to be profitable from operations during the first quarter of 2007, excluding non-cash charges.
Before the news hit the wires, Unicorp's stock closed yesterday at around Thirty Seven cents a share.
In case you are not familiar with the company: Unicorp, Inc is primarily engaged in the acquisition, development, exploration and production of crude oil and natural gas. Its focus is on aggressively acquiring working interests in crude oil and natural gas properties with the intent of exploration and development or by enhancing production through the use of modern development techniques such as horizontal drilling, satellite technology and 3-D seismic. The company's goal is to achieve a high return on its investment by limiting its up-front acquisition costs, by quickly developing its acquisitions and by practicing a sound and smart approach to oil and gas exploration and development.
Chesapeake Energy Corporation (NYSE: CHK) up 2.5% on 17.1 million shares traded.
Chesapeake Energy Corporation is one of the largest independent producers of natural gas in the U.S. Headquartered in Oklahoma City.
TXU Corp. (NYSE: TXU) up 13.1% on 48.4 million shares traded.
TXU Corp., a Dallas-based energy company, manages a portfolio of competitive and regulated energy businesses primarily in Texas.
Evergreen Solar, Inc. (NASDAQ: ESLR) up 6% on 7 million shares traded Evergreen Solar, Inc. develops, manufactures and markets solar power products using proprietary, low-cost manufacturing technologies.
ICE Futures ADV Increases 93%; NYBOT ADV up 18% With Record Monthly Volume; ICE OTC Average Daily Commissions Grow 90% in February
ATLANTA, March 2, 2007 /PRNewswire-FirstCall via COMTEX/ -- IntercontinentalExchange (NYSE: ICE), the leading electronic energy marketplace and soft commodity exchange, today reported significant increases in volume and commissions during the month of February 2007 compared to February 2006. Average daily volume (ADV) for ICE Futures, ICE's U.K. based regulated futures subsidiary, was 492,353 contracts, an increase of 92.8% over ADV in February 2006. Volume at the New York Board of Trade (NYBOT), ICE's wholly-owned U.S. based regulated futures subsidiary, totaled a record 4,886,508 contracts in February 2007, for an ADV of 256,447 contracts, an increase of 17.9% over February 2006. Electronic trading accounted for 32.4% of the total NYBOT soft commodities futures contracts. Average daily commissions in ICE's over-the- counter (OTC) business segment in February 2007 were $800,446, a 90.0% increase over February 2006.
ICE Futures Volume
Total monthly volume at ICE Futures in February 2007 rose 92.8% to 9,847,062 contracts, compared to 5,107,913 contracts in February 2006. ADV for the month also rose 92.8% to 492,353 contracts compared to ADV of 255,396 contracts in February 2006. Excluding trading on President's Day, a U.S. holiday during which the ICE Futures markets were open for trading, average daily volume for the month was 510,186 contracts. Monthly and average daily volume exchange-wide figures in February 2007 represented the second highest totals in the history of the exchange. ICE Brent Crude futures and ICE WTI Crude futures individually recorded their second best volume months in February.
ICE UK Natural Gas futures set a new monthly record of 97,635 contracts in February 2007, surpassing the previous January 2003 monthly record of 95,945; ADV was a record 4,882 contracts, exceeding by 11.9% the January 2003 ADV record.
During the month of February 2007, ICE Futures established several open interest records, including exchange-wide and in ICE Brent Crude, ICE WTI Crude and ICE Gas Oil futures.
In February 2007, the ICE Futures rate per contract (RPC) averaged $1.28, compared to $1.12 in February 2006, when a fee waiver for the ICE WTI Crude futures contract, as well as the previous futures rate structure, were in place. In January 2007, ICE Futures' RPC was $1.30, compared to $1.33 in December 2006 and $1.33 in the fourth quarter of 2006.
About IntercontinentalExchangeIntercontinentalExchange(R ), (NYSE: ICE) operates the leading global, electronic
marketplace for trading both futures and OTC energy contracts and the leading
soft commodity exchange. ICE's markets offer a range of contracts based on crude
oil and refined products, natural gas, power and emissions, as well as soft
commodities including cocoa, coffee, cotton, ethanol, orange juice, wood pulp
and sugar, in addition to currency and index futures and options. ICE(R)
conducts its energy futures markets through its U.K. regulated London-based
subsidiary, ICE Futures, Europe's leading energy exchange. ICE Futures offers
liquid markets in the world's leading oil benchmarks, Brent Crude futures and
West Texas Intermediate (WTI) Crude futures, trading nearly half of the world's
global crude futures by commodity volume. ICE conducts its soft commodity
futures markets through its U.S. regulated subsidiary, the New York Board of
Trade(R). For more than a century, NYBOT(R) has provided global markets for
food, fiber and financial products. ICE was added to the Russell 1000(R) Index
on June 30, 2006. Headquartered in Atlanta, ICE also has offices in Calgary,
Chicago, Houston, London, New York and Singapore. For more information, please
visit www.theice.com and www.nybot.com.
Microsoft Rewards Technology Innovation at KSS with Presentation of Retail Application Developer (RAD) Award KSS PriceStrat Takes Top Honors in Business Insight Category
FLORHAM PARK, N.J., Mar 02, 2007 (BUSINESS WIRE) -- KSS, a global leader in retail price optimization solutions, announced today that Microsoft has awarded the KSS PriceStrat price optimization solution with the Europe/Middle East/Asia (EMEA) Retail Application Development (RAD) award, in the Business Insight category. Microsoft presented KSS with the award Feb 27, 2007, at the RAD award ceremony at the CCD Congress Center in Dusseldorf, Germany.
The awards, which attracted entries from all over the EMEA region including Belgium, France, Israel, South Africa, Sweden, Turkey and the United Kingdom, are designed to reward independent software vendors (ISVs) and retailer IT departments that can successfully demonstrate innovation and excellence by delivering business value using Microsoft(R) technologies in the retail sector. This year's panel of judges was made up of some of the leading figures from the European retail industry: Paivi Hokkanen (Stockmann, Finland), Hansjoerg Bausch (Kaufhof, Germany), Neil Ashworth (Tesco.com, UK), Martin White (Primark, Ireland) and Michael Gerling (EHI Retail Institute, Germany).
"We are excited to receive this prestigious honour from Microsoft in recognition of our PriceStrat solution," said Mark Hawtin, KSS vice president of business development. "PriceStrat, built on the .NET platform, provides retailers around the world with the ability to accurately model and forecast the effects of pricing and promotions decisions, before they are implemented. The business insight that this solution brings to our customers allows them to consistently develop and execute the optimum mix of prices and promotions that satisfy their customers needs and generate desired performance across the store."
About KSS
KSS is the leading supplier of comprehensive pricing intelligence, optimization and execution solutions to the grocery, chain drug, general retail, convenience retail and petroleum industries. The company helps retailers manage more than $70 billion in annual revenue from more than 22,000 outlets. Retailers use KSS software to model, forecast and optimize the effects of pricing and promotional decisions. PriceStrat and other KSS software are available as an on-site, fully integrated system. For more information, visit www.kssg.com. For media inquiries in Europe, contact Mark Hawtin at 0161 228 0040 or hawtinm@kssg.com. For all other media inquiries, contact Roy Miller at (903) 422-5117, or at roy@roygmiller.com.
Schon sehr lange nichts mehr gehört von der!
Genta Incorporated
08.03.07 19:10 Uhr
0,4981 USD
+1,65 % [+0,0081]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=1y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
Börse
NASDAQ
Aktuell
0,4981 USD
Zeit
08.03.07 19:10
Diff. Vortag
+1,65 %
Tages-Vol.
534.359,12
Gehandelte Stück
1,1 Mio
Genta and IDIS Announce Global Ex-U.S. Agreement for Named Patient/Compassionate Use Distribution of Ganite(R) and Genasense(R)
BERKELEY HEIGHTS, N.J. and WEYBRIDGE, U.K., Mar 07, 2007 /PRNewswire via COMTEX/ -- BERKELEY HEIGHTS, N.J. and WEYBRIDGE, U.K., March 7 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) and IDIS today announced the signing of an agreement whereby IDIS will distribute two of Genta's oncology products, Ganite(R) (gallium nitrate injection) and Genasense(R) (oblimersen sodium) Injection, on a named patient/compassionate use basis. The global agreement covers all territories except the United States. "Named patient" distribution refers to the distribution or sale of a product to a specific healthcare professional for the treatment of an individual patient. IDIS, a privately owned company based in the United Kingdom, will manage the named patient programs for Genta.
Ganite is approved and marketed by Genta in the U.S. for treatment of cancer-related hypercalcemia that is resistant to hydration. Early Phase 2 studies using Ganite as an investigational drug to reduce accelerated bone resorption have been completed in patients with bone metastases and in Paget's disease of bone. The drug is currently being tested at higher doses as a direct anticancer agent in patients with relapsed or refractory non-Hodgkin's lymphoma. A Marketing Authorization Application for Genasense plus dacarbazine in patients with advanced melanoma is currently pending review in Europe. Genta is testing Genasense in ongoing clinical trials with other chemotherapy drugs in patients with melanoma and other diseases. The Company expects to allocate a percentage of net proceeds from the IDIS program to support compassionate use in indigent patients; the remainder will support further clinical research.
Natalie Douglas, Managing Director of IDIS, commented: "We are delighted to be working with Genta to manage access to Genasense and Ganite for oncology patients who have the potential to benefit from the Company's innovative therapies."
"Genta is committed to securing regulatory approval of its drugs on a global basis, and we welcome IDIS's assistance with this key program," said Dr. Raymond P. Warrell, Jr., Genta's Chief Executive Officer. "We are pleased to be able to provide these drugs that address critical unmet medical needs to seriously ill patients in response to prescriber requests."
On Wednesday March 7, 2007, management from Genta and IDIS will host a joint conference call and live audio webcast to provide an overview of the agreement at 4:30 pm EST.
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
Atheros Communications, Inc
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ATHR.NAS&lColors=0x000000&sSym=ATHR.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ATHR.NAS&lColors=0x000000&sSym=ATHR.NAS&hcmask=
Sehr gut! Abprall von den unteren Bollingerbänder nach oben!
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ATHR.NAS&lColors=0x000000&sSym=ATHR.NAS&hcmask=
Ivanhoe Energy, Inc. - Common Shares
08.03.07 19:43 Uhr
2,11 USD
+0,48 % [+0,01]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=IVAN.NAS&lColors=0x000000&sSym=IVAN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=IVAN.NAS&lColors=0x000000&sSym=IVAN.NAS&hcmask=
Nach solch einemAnstieg wird die Luft immer dünner!
http://isht.comdirect.de/charts/large.chart?hist=3m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=IVAN.NAS&lColors=0x000000&sSym=IVAN.NAS&hcmask=
Börse
NASDAQ
Aktuell
2,11 USD
Zeit
08.03.07 19:43
Diff. Vortag
+0,48 %
Tages-Vol.
7,31 Mio.
Gehandelte Stück
3,5 Mio
Ivanhoe Energy Inc. (NASDAQ: IVAN) up 6% on 6 million shares traded Ivanhoe Energy is an independent international oil and gas development and production company focused on pursuing long-term growth in its reserves and production using advanced technologies, including its proprietary heavy oil upgrading process (HTL).
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=1y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
Ganz schön weit entfernt von ihrem Hoch!! Dem Markt gefält der Merger nicht!
http://isht.comdirect.de/charts/large.chart?hist=5y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SIRI.NAS&lColors=0x000000&sSym=SIRI.NAS&hcmask=
Karmazin Says XM/Sirius Subscriptions Will be Discounted
(financialwire.net via COMTEX) -- March 8, 2007 (FinancialWire) Sirius (NASDAQ: SIRI) CEO Mel Karmazin said that subscription service for the combined XM and Sirius satellite radio merger would be substantially discounted for customers.
The service costs $12.95 each. When asked if the programming of the combined conglomerate would cost $26 per month Karmazin said that there would be a substantial discount that would likely be in the range of $10 off.
XM and Sirius are trying to merge but the proposal may be against US antitrust restrictions. Karmazin has maintained that the deal will be good for subscribers, who will benefit from both companies but will not have to pay substantially more for the deal.
CKE RESTAURANTS
08.03.07 20:04 Uhr
18,99 USD
+2,37 % [+0,44]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=CKR.NYS&lColors=0x000000&sSym=CKR.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=CKR.NYS&lColors=0x000000&sSym=CKR.NYS&hcmask=
Das Ergebnis hat geholfen! Jetzt ist wieder Platz auf die 20.
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=CKR.NYS&lColors=0x000000&sSym=CKR.NYS&hcmask=
Börse
NYSE
Aktuell
18,99 USD
Zeit
08.03.07 20:04
Diff. Vortag
+2,37 %
Tages-Vol.
20,89 Mio.
Gehandelte Stück
1,1 Mio.
CKE Restaurants, Inc. Reports Period One Blended Same-Store Sales Both Brands Report Historically High Period One Average Unit Volumes
CARPINTERIA, Calif., March 7, 2007 /PRNewswire-FirstCall via COMTEX/ -- CKE Restaurants, Inc. (NYSE: CKR) announced today period one same-store sales for the four weeks ended Feb. 26, 2007, for Carl's Jr.(R) and Hardee's(R).
Brand Period 1
FY 2008 FY 2007
Carl's Jr. -2.7% +10.2%
Hardee's +1.5% +4.3%
Blended -0.5% +7.3%Commenting on the Company's performance, Andrew F. Puzder, president and chief
executive officer, said, "Despite the 16th consecutive period of positive
same-store sales for our Hardee's brand, blended same-store sales for period one
declined 0.5 percent due to a negative 2.7 percent period for Carl's Jr. We
remain very optimistic about the potential future near- and long-term
performance of both our brands based upon our continued focus on innovative
premium products, cutting-edge advertising, customer service, remodels and
dual-branding conversions.""Obviously, we would love to report same-store sales increases every period for
all of our concepts. This becomes very difficult when rolling over strong
product introductions and favorable weather conditions resulting in strong
same-store sales (+10.2% at Carl's Jr.). However, through the first week of
period two, Carl's Jr. same-store sales appear to be rebounding.""One reason for this rebound is the Buffalo Chicken Sandwich(TM) which Carl's
Jr. introduced on Feb. 21. However, media support for the product only began
during the final two days of period one. Featuring a crispy chicken breast
fillet dipped in Frank's(R) RedHot(R) buffalo wing sauce, and topped with ranch
dressing, tomato and lettuce, the spiciness of the sandwich is only matched by
the television commercial that debuted during the Academy Awards in most
markets. The spot, starring model/actress Ashley Hartman, is another example of
the cutting-edge advertising for which our brands are known. Consumers can view
the commercial at the micro-website http://www.spicybuffalo.com," said Puzder
"Carl's Jr. also featured the Chipotle Chicken Salad(TM) during the period. On a
two-year cumulative basis, same-store sales at Carl's Jr. have increased
approximately seven and a half percent. Further, average unit volume for period
one was higher than any comparable period one in the brand's history." Revenue
for period one from company-operated Carl's Jr. restaurants (exclusive of
franchise-related revenue and royalties) was approximately $44.1 million."The Hardee's brand, which continued its positive same-store sales trend despite
less favorable weather in the current year, also launched the Buffalo Chicken
Sandwich and Ashley Hartman television spot during the period. As with Carl's
Jr., media began only during the last few days of the period. In addition,
Hardee's continued to promote the Big Twin(R), the Southwest Chicken Salad(TM),
and the aptly named Monster Biscuit(TM) during the breakfast daypart," Puzder
continued. "On a two-year cumulative basis, Hardee's same- store sales have
increased more than five and a half percent. In addition, Hardee's period one
average unit volume was higher than any comparable period one since fiscal 1994,
which is as far back as we can check." Revenue for period one from
company-operated Hardee's restaurants (exclusive of franchise- related revenue
and royalties) was approximately $48.2 million
Salix Pharmaceuticals, Ltd.
08.03.07 21:05 Uhr
12,80 USD
-0,16 % [-0,02]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SLXP.NAS&lColors=0x000000&sSym=SLXP.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=SLXP.NAS&lColors=0x000000&sSym=SLXP.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SLXP.NAS&lColors=0x000000&sSym=SLXP.NAS&hcmask=
Börse
NASDAQ
Aktuell
12,80 USD
Zeit
08.03.07 21:05
Diff. Vortag
-0,16 %
Tages-Vol.
6,79 Mio.
Gehandelte Stück
532.155
CHICAGO, Mar 05, 2007 (BUSINESS WIRE) --
Seeking Visibility on Salix Programs
Although we expect Salix Pharmaceuticals (Nasdaq: SLXP) to post decent top-line and bottom-line growth over the next few years, we remain concerned about the growth prospects of Colazal, the company's lead product. Colazal is likely to face intense competition with the entry of Shire's (Nasdaq: SHPGY) Lialda, and is also in danger of facing generics.
We believe that investor focus will remain on Salix's ability to execute on its life-cycle extension program for Colazal. Valuation is attractive in our view, but we would like more visibility on the Colazal life-cycle extension program before we recommend the shares. We rate the stock a Hold, with a $15 target.
We also believe that Salix offers average risk for the biotech group, but would like to see more proof that its antibiotic Xifaxan will drive shareholder value once the posted sales begin to match the prescription trends. While the company succeeded in bringing down inventory levels for Xifaxan and Colazal, it is still a long way from achieving normal inventory levels. This remains a matter of concern. The inventory situation together with the low visibility on Colazal will probably continue to keep the shares in check. Salix shares should be protected on the downside based on the potential to post 25% top-line growth over the next several years.
Halliburton´s Flucht nach Dubai
Mit der katastrophalen Pleite des einstigen Energieriesen Enron hat Houston, Texas, vor sechs Jahren seinen größten Arbeitgeber verloren. Jetzt zieht die Nummer Zwei ab: Halliburton, einer der größten Dienstleitser für die Öl- und Kriegsbranche, verlegt seinen Sitz nach Dubai. Für einige Manager wird es höchste Zeit.
Die jüngste Geschichte von Halliburton ist erstaunlich von vorne bis hinten. Das Unternehmen, das von 1995 bis 1999 vom heutigen amerikanischen Vize-Präsidenten Dick Cheney geführt wurde, hat in den letzten Jahren massiv von seiner Nähe zur Politik in Washington profitiert – und konnte ungestört walten. Es dauerte nicht lange, bis man seine Ausnahmeposition schonungslos ausnutzte und missbrauchte.
Das begann mit dem Einzug der amerikanischen Truppen im Irak. Von Anfang an war Halliburton mit dabei – das Unternehmen war für die Infrastruktur vor Ort verantwortlich, versorgte die Soldaten mit Unterkünften, Essen und Trinken, unterhielt Waschküchen und stellte schusssichere Westen und ähnliche Rüstung zur Verfügung. Dafür wurde Halliburton vom Steuerzahler entlohnt, den man nach allen Regeln der Kunst schröpfte.
Während das Unternehmen den Soldaten nämlich verdorbenes Essen servierte und verunreinigtes Flusswasser aus dem Euphrat anbot, stellte man Washington Fantasie-Rechnungen. Pro Cola-Dose wurden 45 Dollar abgerechnet, pro Wäsche-Sack 100 Dollar. Und mehrfech wurde berichtet, wie Halliburton-Mitarbeiter alte Trucks nach einer Panne am Straßenrand einfach stehen ließen und das Unternehme auf Staatskosten einen neuen anschaffte.
Ähnlich verhielt es sich mi Personalkosten: Hunderte von Arbeitern hatte Halliburton im Irak stationiert, für die es nichts zu tun gab. Sie saßen folglich untätig herum, mussten auf Anweisung aus dem Management aber zwölf Arbeitsstunden täglich abrechnen, für sieben Tage in der Woche.
Eine unabhängige Untersuchung ergab vor zwei Jahren, dass Halliburton mehr als 2,7 Milliarden Dollar in Washington direkt ergaunerte – das entspricht mehr als 10 Prozent des gesamten Auftragswertes von etwa 25 Milliarden Dollar, den Halliburton im Irak hatte. Möglich war das dank der Rückendeckung von Bush, Cheney und Co. Tom Davis, der republikanische Senator aus Virginia und Vorsitzender im Kommittee für Regierungsreformen in Washington, hatte offizielle Anfragen der Demokraten stets abgewiesen.
Die Geschäfte im Irak sind nicht der einzige Grund, warum Halliburton immer wieder in die Schusslinie gerät. Seit Jahren unterhält der Konzern beste Beziehungen in den Iran, mit dem amerikanische Firmen offiziell keine Geschäfte tätigen dürfen. Dass Halliburton ebendies über eine Tochtergesellschaft auf den Cayman Islands tat, machte die regelmäßigen Millionen-Deals legal – wenn auch nicht legitim.
Mit dem Regierungswechsel in Washington wären die nächsten Jahre ungemütlich geworden für Halliburton. Zahlreiche demokratische Politiker haben sich Untersuchungen gegen den Konzern auf die Fahnen geschrieben – dem entgeht man nun durch einen Schritt, der sich nur als Flucht klassifizieren lässt. Flucht vor der Verantwortung und den Folgen. Denn dass illegale Machenschaften auch Top-Manager ins Gefängnis bringen, das hat man beim Nachbarn Enron gesehen.
Lars Halter
WCI COMMUNITIES INC
13.03.07 16:21 Uhr
22,23 USD
+17,19 % [+3,26]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=WCI.NYS&lColors=0x000000&sSym=WCI.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=WCI.NYS&lColors=0x000000&sSym=WCI.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=WCI.NYS&lColors=0x000000&sSym=WCI.NYS&hcmask=
Börse
NYSE
Aktuell
22,23 USD
Zeit
13.03.07 16:21
Diff. Vortag
+17,19 %
Tages-Vol.
90,37 Mio.
Gehandelte Stück
4,8 Mio.
Icahn Affiliates to Make Tender Offer for Shares of WCI Communities, Inc. at $22.00 Per Share
NEW YORK, March 13, 2007 /PRNewswire via COMTEX/ -- Carl Icahn today announced that his affiliated entities, High River Limited Partnership and entities managed by Icahn Management LP, intend to initiate an "any and all" tender offer, not subject to any minimum condition, for the common stock of WCI Communities, Inc. at $22.00 per share.
Closing of the tender offer will be subject to, among other things, the redemption of the Company's recently adopted "poison pill" by the board. Mr. Icahn indicated that to the extent the current board prevents the conditions from being satisfied, he intends to leave the tender offer open and intends that our proposed nominees, if elected, would, subject to their fiduciary duties, cause the conditions to be met so that the $22.00 "any and all" tender offer can be consummated. The tender offer will not be subject to due diligence or financing.
Mr. Icahn stated that, "we believe that the board and CEO of WCI have not enabled the Company to maximize the potential of its unique set of assets which trade at a discount to their GAAP book value. If elected, we expect our slate, in a manner consistent with their fiduciary duties, to ensure these unique assets are properly marshaled through the current residential housing industry downturn."
WCI's board and CEO have stated emphatically and more than once that now is not the time to sell the Company. Mr. Icahn commented, "This is one of the very few times that management has been correct about anything." Mr. Icahn continued, "While clearly now is not the right time to sell, in my opinion Mr. Starkey and the current board are not qualified to navigate WCI through the difficult industry conditions that lie ahead. We question whether Mr. Starkey and the current board have the ability or the expertise to take advantage of the complex strategic opportunities that I believe may present themselves. Additionally, mergers, including the possible sale of the company in the future at the right time and price, may be overlooked by the current board."
Carl Icahn concluded that "this tender offer will be in the best interests of all shareholders in that it would provide immediate liquidity at a premium for those shareholders who are concerned with the current housing industry downturn while also providing the opportunity for those shareholders who, like us, believe in the long-term prospects of the company to realize any potential upside."
Accredited Home Lenders Holding Co.
13.03.07 16:42 Uhr
5,029 USD
-55,89 % [-6,371]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=LEND.NAS&lColors=0x000000&sSym=LEND.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=LEND.NAS&lColors=0x000000&sSym=LEND.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=LEND.NAS&lColors=0x000000&sSym=LEND.NAS&hcmask=
Börse
NASDAQ
Aktuell
5,029 USD
Zeit
13.03.07 16:42
Diff. Vortag
-55,89 %
Tages-Vol.
90,85 Mio.
Gehandelte Stück
18 Mio.
Accredited Pursuing Strategic Options
SAN DIEGO, Mar 13, 2007 (BUSINESS WIRE) -- Accredited Home Lenders Holding Co. (NASDAQ: LEND) ("Accredited" or "Company") announced today that it is currently exploring various strategic options, including raising additional capital to enhance liquidity and provide the Company with the flexibility to retain or sell originated loans based on an assessment of the best overall return. Accredited's available cash resources have been affected primarily by margin calls under its warehouse and repurchase facilities since January 1, 2007, all of which have been met to date, as well as ongoing loan repurchases. The Company reported that it has paid approximately $190 million in margin calls on its facilities since January 1, 2007. Approximately two-thirds of those margin calls have been received and paid since February 15, 2007.
In addition, Accredited is seeking waivers and extensions of waivers of certain financial and operating covenants under its warehouse and repurchase facilities, including waivers relating to required levels of net income. The Company has been operating under various waivers under these facilities since December 31, 2006. There can be no assurance that the Company will be successful in receiving any of the required waivers.
Accredited also reported that it is pursuing certain cost restructuring initiatives, including further workforce reductions.
The Company continues to evaluate impairment of the goodwill established in its acquisition of Aames Investment Corporation ("Aames") in the fourth quarter of 2006. In light of this evaluation, along with work that must be completed for the Company's year-end audit, it is unlikely that the Company will file its Annual Report on Form 10-K by March 16, 2007 as previously contemplated in its Notification of Late Filing on Form 12b-25 filed with the Securities and Exchange Commission on March 1, 2007.
j2 Global Communications Inc
13.03.07 16:56 Uhr
27,96 USD
+13,20 % [+3,26]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=JCOM.NAS&lColors=0x000000&sSym=JCOM.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=JCOM.NAS&lColors=0x000000&sSym=JCOM.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=JCOM.NAS&lColors=0x000000&sSym=JCOM.NAS&hcmask=
Börse
NASDAQ
Aktuell
27,96 USD
Zeit
13.03.07 16:56
Diff. Vortag
+13,20 %
Tages-Vol.
82,94 Mio.
Gehandelte Stück
3,1 Mio.
bellwetherreport.com: Shareholders alert for J2 Global Communications, Inc
Mar 13, 2007 (M2 PRESSWIRE via COMTEX) -- Shareholders alert for J2 Global Communications, Inc (NASDAQ: JCOM)
j2 Global Communications, Inc. provides outsourced, value added messaging and communications services to individuals and businesses worldwide. It offers an array of faxing solutions, including Web-based fax and fax broadcasting at eFax.com; and a suite of unified communications services, including fax, Web-based voicemail, and conference calling at j2.com; as well as a conference calling service to its business services at consensus.com and a unified communications service through Onebox.com. The company�s customer support services include support to its customers through a combination of on-line self-help, email messages, interactive chat sessions, and telephone calls. As of December 31, 2005, it had 54 physical points of presence, as well as delivered its services through its global telephony/Internet protocol network that covered approximately 2,000 cities in 26 countries across 5 continents. The company serves various customers, including individuals, small to medium-sized businesses, and enterprises and government organizations. j2 Global Communications was co-founded by Jaye Muller and Jack Riley in 1995 and is headquartered in Los Angeles, California.
Shares were up 6% after the outsourcing company brought its filings up to date.
Shares of J2 Global Communications Inc. rose in premarket trading Tuesday after the outsourcing company brought its filings up to date and said a price increase hasn't scared away many customers.
J2 Global, which delayed filing earnings reports because of an investigation into the timing of its stock options, filed two quarterly reports and an annual report Monday.
Based in Los Angeles, J2 Global provides faxing, voicemail and e-mail to companies looking to outsource communications processes. With $181 million in annual sales, J2 Global had 907,000 subscribers at the end of 2006.
Jefferies & Co. analyst Youssef Squali upgraded J2 Global to "Buy" from "Hold." He said the filings bring the investigation into options pricing to a close, which will focus investors on the company's promising prospects.
J2 Global raised prices 31 percent, Squali said, yet only 2.9 percent of customers let their subscriptions lapse. That's a little higher than normal, he said, but encouraging considering the price hike.
Squali raised his price target to $31 from $27. The new target is 25.5 percent higher than the stock's closing trade of $24.70 on the Nasdaq Stock Market Monday.
Google Inc.
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
Google hat den Abwärtstrend nicht verlassen!
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
Genta Incorporated
23.03.07 21:00 Uhr
0,402 USD
+1,85 % [+0,0073]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&ind0=VOLUME&&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=1y&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
Zur Bedeutungslosigkeit geschrumpft! Bei anderen Charts sieht man das genae Gegenteil. Aber es schaut nach einer Bodenbildung aUS1
http://isht.comdirect.de/charts/large.chart?hist=5y&type=candle&ind0=VOLUME&¤cy=&lSyms=GNTA.NAS&lColors=0x000000&sSym=GNTA.NAS&hcmask=
Börse
NASDAQ
Aktuell
0,402 USD
Zeit
23.03.07 21:00
Diff. Vortag
+1,85 %
Tages-Vol.
792.551,94
Gehandelte Stück
2 Mio.
15.03.2007 14:01
Genta Announces Closing of Common Stock Offering
BERKELEY HEIGHTS, N.J., March 15 /PRNewswire-FirstCall/ -- Genta Incorporated (Nachrichten) announced that the Company has closed the previously announced offering of 30 million shares of common stock for gross proceeds totaling approximately $11 million before fees and expenses. The shares were sold pursuant to the Company's registration statement on Form S-3 declared effective by the Securities and Exchange Commission on May 11, 2004. Rodman&Renshaw, LLC served as the placement agent for the offering.
"The Company is looking forward to several key regulatory milestones, including the regulatory opinion from Europe on the Genasense marketing application for patients with advanced melanoma", said Dr. Raymond P. Warrell, Jr., Genta's Chief Executive Officer. "We are also on track to file this month our appeal of the initial decision by the U.S. Food and Drug Administration on Genasense in patients with relapsed and refractory chronic lymphocytic leukemia. Proceeds from this offering will be used to support general corporate activities, including product sales from the recently announced named-patient distribution programs for Ganite and Genasense, and we expect to ship the initial inventory for that program next week."
This communication shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The shares of common stock may only be offered by means of a prospectus. Copies of the final prospectus supplement and accompanying base prospectus can be obtained from Rodman&Renshaw, LLC at 1270 Avenue of the Americas, New York, NY 10017. Fax # 212-356-0536
About Genta
Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs that center on oligonucleotides (RNA- and DNA- based medicines) and small molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its oligonucleotide program. Genta has completed a pending Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment of patients with advanced melanoma. The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. Genta is partnered with IDIS on a program whereby both Ganite and Genasense are available to cancer patients on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our website at: http://www.genta.com/.
Yahoo! Inc
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=YHOO.NAS&lColors=0x000000&sSym=YHOO.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=YHOO.NAS&lColors=0x000000&sSym=YHOO.NAS&hcmask=
Bei Yahoo sehe ich mehr Potential als bei Google!
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=YHOO.NAS&lColors=0x000000&sSym=YHOO.NAS&hcmask=
Sonus Networks, Inc
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SONS.NAS&lColors=0x000000&sSym=SONS.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=SONS.NAS&lColors=0x000000&sSym=SONS.NAS&hcmask=
Hat sich super erholt!
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=SONS.NAS&lColors=0x000000&sSym=SONS.NAS&hcmask=
GrowthStockAlert.net: Stocks to Watch for Tuesday, March 27, 2007: (OTCBB: PGNE) , (NYSE:LUM), (PinkSheets: RCAU),. (NASDAQ: SONS), (PinkSheets: BIPH)
Mar 27, 2007 (M2 PRESSWIRE via COMTEX) -- Stocks To Watch: PrimeGen Energy Corporation(OTCBB: PGNE) , Luminent Mortgage Capital, Inc (NYSE:LUM), SGT GROUP INC (PinkSheets: RCAU), Sonus Networks, Inc. (NASDAQ: SONS), Biophan Technologies (PinkSheets: BIPH)
FEATURED STOCK: PrimeGen Energy Corporation (OTCBB: PGNE) Current Price (1.50) www.growthstockalert.net
PrimeGen Energy's (OTCBB: PGNE) High Expectations for Upcoming Shale Gas Venture
The Fayetteville Shale play located in Van Buren, Stone and Cleburne Counties, has the potential to become a significant on-shore natural gas play.
PrimeGen Energy Corporation (OTCBB: PGNE) works to acquire interests in leaseholds that either are in production, near to production, or demonstrate significant exploration potential. PrimeGen Energy Corporation owns a 10% working interest in roughly 40,000 acres, where the geological characteristics are analogous to other successful projects in the area. PrimeGen is delighted to have attained membership in this upcoming shale gas venture.
Luminent Mortgage Capital, Inc (NYSE:LUM) Current Price (9.05) SAN FRANCISCO, March 21 -- Luminent Mortgage Capital, Inc. (NYSE: LUM - News) announced today that Dimitrios Papatheoharis, CFA will join Luminent Mortgage Capital, Inc. in April 2007 as Senior Vice President and Chief Investment Officer. Luminent Mortgage Capital, Inc., a real estate investment trust (REIT), invests primarily in the United States agency and other single-family, adjustable-rate, and fixed rate mortgage-backed securities. The company has elected to be taxed as a REIT under the Internal Revenue Code of 1986. As a REIT, it would not be subject to federal income tax purposes, provided that it distributes at least 90% of its REIT taxable income to its shareholders. Luminent Mortgage was founded in 2003 and is headquartered in San Francisco, California.
SGT GROUP INC (PinkSheets: RCAU) Current Price (1.70) ORLANDO, Fla.----CompleteAuto, an RCAU Company (Pink Sheets:RCAU - News), announced today that they have received certification from eBay Motors to operate as a Solutions Provider in eBay Motors' Local Market Program. Through their state-of-the-art vehicle listing software, CompleteAuto currently offers automobile dealers the ability to reach buyers all across the country through online auctions via eBay Motors. Certification by eBay Motors in the Launch of their new Local Market Program will now allow dealers to utilize the CompleteAuto software to bring more local buyers directly into their dealerships, making the eBay selling process more simplistic.
Sonus Networks, Inc.
(NASDAQ: SONS) Current Price (8.56) WESTFORD, Mass., March 22 -- Sonus Networks, Inc. (Nasdaq: SONS - News), a leading supplier of service provider Voice over IP (VoIP) infrastructure solutions, announced today that some of the industry's most innovative companies have joined the Sonus Interoperability Certification Program at the University of New Hampshire InterOperability Lab (UNH-IOL), which is designed to help promote successful interoperability in multi-vendor networks. The Sonus Certification program was launched as part of the Open Services Partner Alliance, the industry's pioneer Session Initiation Protocol (SIP) interoperability testing organization, to advance further network operators' ability to deploy solutions from multiple vendors within their networks.
Sonus Networks, Inc. is a leading provider of Voice over IP (VoIP) infrastructure solutions for wireline and wireless service providers. With its comprehensive IP Multimedia Subsystem (IMS) solution, Sonus addresses the full range of carrier applications, including residential and business voice services, wireless voice and multimedia, trunking and tandem switching, carrier interconnection and enhanced services. Sonus' voice infrastructure solutions are deployed in service provider networks worldwide.
Founded in 1997, Sonus is headquartered in Westford, Massachusetts. Additional information on Sonus is available at http://www.sonusnet.com
Biophan Technologies (PinkSheets: BIPH) Current Price (0.37) EL DORADO HILLS, Calif.---Dutton Associates updates its coverage of Biophan Technologies (OTCBB:BIPH - News) maintaining a Neutral rating. The 12-page report by Dutton senior analyst Richard W. West, CFA is available at www.jmdutton.com, and from First Call, Bloomberg, Zacks, Reuters, Knobias, and other leading financial portals. Biophan Technologies, Inc. engages in the development and commercialization of technologies for use with medical procedures and biomedical devices. Its technologies enable medical systems, such as pacemakers; interventional surgical devices, including catheters and guidewires; and implants, such as stents to be implantable, safe, and image compatible with magnetic resonance imaging (MRI). The company is also developing and marketing an image compatible ceramic motor; a system for generating power for implantable devices from body heat; and a series of implantable devices, including MRI-visible vascular implants, such as a vena cava filter, a heart valve, and an occluder for the treatment of atrial septal defects, a hole in the wall separating the left and right chambers of the heart. In addition, Biophan Technologies has interest in MYOTECH, LLC that develops and commercializes the MYO-VAD, MRI-compatible ventricular assist device for the treatment of heart disease. Further, it has joint development and licensing agreements with Boston Scientific Corporation, NASA Ames Center for Nanotechnology, and Nanoset, LLC, as well as has a cooperative research and development agreement with the U.S. FDA to develop standards for making pacemakers, defibrillators, and neurostimulators safe with MRI. The company was founded in 1963. It was formerly known as Idaho Copper and Gold, Inc. and changed its name to Idaho Technical, Inc. in 1999. Further, the company changed its name to GreatBio Technologies, Inc. in 2000 and to Biophan Technologies, Inc. in 2001. Biophan Technologies is headquartered in Pittsford, New York.
BUYINS.NET: PCYC, PGIC, NTRZ, CCCFF, FOLGF Have Also Been Removed From Naked Short List Today
Mar 27, 2007 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold list:
Pharmacyclics Inc. (NASDAQ: PCYC),
Progressive Gaming International Corporation (NASDAQ: PGIC),
Nutracea (OTCBB: NTRZ),
Chai-Na-Ta Corp. (OTCBB: CCCFF),
Falcon Oil & Gas Ltd (OTC: FOLGF)
Pharmacyclics Inc. (NASDAQ: PCYC) a pharmaceutical company, is developing drugs to treat cancer and other diseases. Its pharmaceutical agents are synthetic small molecules designed to target key biochemical pathways in diseased cells. The company's principal development products include Xcytrin injection, an anti-cancer agent that is in phase II clinical trials; and Histone Deacetylase Inhibitor, a phase I clinical trial product that targets histone deacetylase enzymes and inhibits their function. Its other development products comprise HDAC-8 selective inhibitor, a preclinical stage drug for the treatment of cancer; a small molecule inhibitor of Factor VIIa, which has demonstrated anti-angiogenic and anti-cancer activity in the laboratory and inhibitors of tyrosine kinase enzymes; and B cell associated tyrosine kinase inhibitors for the treatment of lymphomas and autoimmune diseases. The company has a collaboration and license agreement with the National Cancer Institute. Pharmacyclics was founded in 1991 and is headquartered in Sunnyvale, California. With 25.94 million shares outstanding and 4.15 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of PCYC.
Progressive Gaming International Corporation (NASDAQ: PGIC) supplies integrated casino and jackpot management solutions for the gaming industry worldwide. It operates in two segments, Slot and Table Games, and Systems. The Slot and Table Games segment develops, acquires, licenses, and distributes proprietary branded and non-branded table games, such as World Series of Poker Texas Hold Em Bonus, Texas Hold Em Bonus, Caribbean Stud, Two-Card Joker Poker, Progressive Blackjack, Progressive Baccarat, and various blackjack and poker derivatives; and slot games, including licensed branded game offerings based upon popular brands, including KISS, Garfield, The Beach Boys, and Wink Martindale, as well as non-branded games and mystery concepts, such as Graveyard Bash and Office Daze. The System segment offers a suite of software systems under the Casinolink Enterprise Edition umbrella. The Casinolink Enterprise Edition comprises Casinolink Patron Suite, which offers reception, player tracking, and marketing functionality; Casinolink Intelligence Suite that provides casinos with products to manage cage and pit operations, cashless gaming, and slot accounting and security functionality; and Casinolink Gaming Suite, which provides casinos with slot jackpot management tools, player bonusing, and media management functionality, as well as sports wagering and server-based gaming products. This integrated suite of software products centralizes gaming management, including functions, such as slots and tables monitoring, reporting, and accounting across various casino properties. Progressive Gaming International's customers include casinos, other gaming suppliers, operators of wide-area gaming networks, and lottery authorities. The company was founded in 1986. It was formerly known as Mikohn Gaming Corporation and changed its name to Progressive Gaming International Corporation in 2006. The company is headquartered in Las Vegas, Nevada. With 34.67 million shares outstanding and 8.13 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of PGIC.
Nutracea (OTCBB: NTRZ) a health science company, engages in the development and distribution of stabilized rice bran and rice bran-based products for the consumer food and animal feed sectors. Its products include food supplements and medical foods for humans and animals, as well as cosmetics and beauty aids based on stabilized rice bran, rice bran derivatives, and rice bran oils. The company's customers include consumer nutrition and healthcare companies, domestic and international food companies, and companion animal feed manufacturers. NutraCea was founded in 2000. The company was formerly known as NutraStar Incorporated and changed its name to NutraCea in 2003. NutraCea is based in El Dorado Hills, California. With 87.12 million shares outstanding and 1.91 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of NTRZ.
Chai-Na-Ta Corp. (OTCBB: CCCFF) , based in Richmond, British Columbia, is the world's largest supplier of North American ginseng. The Company farms, processes and distributes North American ginseng as bulk root, and supplies processed material for the manufacture of value-added ginseng-based products. With 34.70 million shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of CCCFF.
Falcon Oil & Gas Ltd (OTC: FOLGF) is a British Columbia corporation which is in the business of oil and gas exploration and production. It has operations in Hungary through its wholly-owned subsidiary TXM Oil and Gas Exploration, LLC, and in Romania through its wholly-owned subsidiary JVX Energy Corporation. With 322.68 million shares outstanding and 25 shares declared short as of February 2007, there is no longer a failure to deliver in shares of FOLGF.
BUYINS.NET: MYS, IMX, CPWM, DCGN, GMXR, LMRA Have Been Removed From Naked Short List Today
Mar 27, 2007 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold list:
Masisa S.A. (NYSE: MYS),
Implant Sciences Corporation (AMEX: IMX),
Cost Plus, Inc. (NASDAQ: CPWM),
deCODE genetics Inc (NASDAQ: DCGN),
GMX Resources Inc (NASDAQ: GMXR),
Lumera Corporation (NASDAQ: LMRA).
Masisa S.A. (NYSE: MYS) a vertically integrated forestry and wood products company, produces sawn lumber, saw and pulp logs wood boards, and solid wood products. Its principal board products include medium density fiberboard (MDF), particle board, and oriented strand board that are principally sold in the Latin American region. The company also produces products, such as MDF mouldings, finger-joint mouldings, and solid wood doors. Its other products comprise wood shavings, wood chips, sawdust, door parts, fiberboard doors, and pine veneer wood plies. Masisa sells its products primarily to the construction and furniture industries, primarily in Latin America and the United States, as well as to customers in other markets, such as Europe and Asia. The company was formerly known as Terranova S.A. and changed its name to Masisa S.A. in 2005. Masisa is headquartered in Santiago, Chile. Masisa S.A. is a subsidiary of Grupo Nueva S.A. With 113.36 million shares outstanding and 50,677 shares declared short as of February 2007, there is no longer a failure to deliver in shares of MYS.
Implant Sciences Corporation (AMEX: IMX) engages in the development, manufacturing, and marketing of products using ion implantation and thin film coatings for medical device applications and semiconductor wafer processing. It offers a range of medical products, including I-Plant Iodine-125 radioactive seed for the treatment of prostate cancer; treatment planning software that enables the physician in making two and three dimensional maps of the stage, grade, and location of cancer within the prostate gland; Ytterbium-192 for breast cancer therapy; orthopedic hip and knee total joint replacements; and biocompatible radiopaque and other coatings. The company also offers ion implantation and analytical services, and disk refurbishment services, as well as source conditioning equipment to semiconductor manufacturers, research laboratories, and research universities. In addition, it supplies trace explosives detection equipment, which detects the vapor from trace amounts of explosive compounds, including plastic explosives, such as RDX, the compound commonly found in C4 explosives. The company was incorporated in 1984 and is based in Wakefield, Massachusetts. With 11.8 million shares outstanding and 194,996 shares declared short as of February 2007, there is no longer a failure to deliver in shares of IMX.
Cost Plus, Inc. (NASDAQ: CPWM) and its subsidiaries operate as a specialty retailer of casual home furnishings and entertaining products in the United States. It offers a range of home decorating items, such as furniture, rugs, pillows, lamps, window coverings, frames, and baskets; furniture products, including ready-to-assemble living and dining room pieces, unusual handcrafted case goods, and occasional pieces; and outdoor furniture made from various materials, such as rattan, hardwood, and wrought iron. The company sells various tabletop and kitchen items, including glassware, ceramics, textiles, and cooking utensils. It also provides various gift and decorative accessories, including collectibles, cards, wrapping paper, and holiday and other seasonal items. In addition, the company offers a selection of gourmet foods and beverages, including wine, microbrewed and imported beer, coffee, tea, and bottled water. As of March 31, 2006, Cost Plus operated 271 stores under World Market, Cost Plus World Market, Cost Plus Imports, and World Market Stores names in 34 states. The company was founded in 1946 and is headquartered in Oakland, California. With 22.08 million shares outstanding and 6.24 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of CPWM.
deCODE genetics Inc. (NASDAQ: DCGN) operates as a biopharmaceutical company in the United States and Iceland. It applies its discoveries in human genetics to the development of drugs for common diseases. The company involves in human genetics, and integrated drug discovery and development activities to offer products and services in various areas, including DNA-based diagnostics, bioinformatics, genotyping, structural biology, drug discovery, and clinical development. It develops DG031 for the prevention of heart attack that completed a series of Phase II clinical trials in Iceland; and DG041 for peripheral artery disease, a form of atherosclerosis that constricts blood flow to the legs and arms, which completed the Phase I clinical program, as well as conducts a Phase II trial on behalf of the developer of a compound for asthma. deCODE genetics has a strategic alliance with Illumina, Inc. for the development and commercialization of DNA-based diagnostic tests in various disease areas; a collaboration with F. Hoffmann-La Roche for the codevelopment of inhibitors of PDE4 for the prevention and treatment of vascular disease; and an alliance with Merck & Co, Inc. to develop treatments for obesity. The company was co-founded by Kari Stefansson and Jeffrey Gulcher in 1996 and is headquartered in Reykjavik, Iceland. With 61.54 million shares outstanding and 5.13 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of DCGN.
GMX Resources Inc. (NASDAQ: GMXR) and its subsidiaries engage in the acquisition, exploration, and development of properties for the production of crude oil and natural gas in Texas, Louisiana, and New Mexico. Its drilling, development, and production activities primarily focus on the Cotton Valley Sands in the Carthage, North Field of Harrison and Panola counties of east Texas. As of December 31, 2006, the company had proved reserves of 258,403 million cubic feet of natural gas equivalent and 95.8 net producing wells. It also has a joint development agreement with Penn Virginia Oil & Gas, L.P. for the development of properties in Carthage, North Field. The company was founded in 1998 and is headquartered in Oklahoma City, Oklahoma. With 11.24 million shares outstanding and 1.69 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of GMXR.
Lumera Corporation (NASDAQ: LMRA) engages in the development, manufacture, and marketing of devices using proprietary polymer materials primarily in the United States. It offers proprietary polymer materials and products based on these materials for bioscience and electro-optics markets. The company's products include biotechnology disposables, which are manufactured with a proprietary polymer coating and process to provide high sample spot density for cost effective solutions for bioassay testing; and electro-optic devices, which translates and encodes data from electronic signals into optical signals that can be used in communications systems and in optical interconnects for high-speed data communication. Its bioscience products are used for DNA and protein analysis, drug development, screening and drug toxicity testing. The company's electro-optic device is used in satellite communications, optical switching for telecom components, high speed signal processing, terahertz imaging, and defense/aerospace. In addition it develops customized polymer-based applications for government agencies. Lumera Corporation was founded in 2000 and is headquartered in Bothell, Washington. With 16.95 million shares outstanding and 3.41 million shares declared short as of February 2007, there is no longer a failure to deliver in shares of LMRA.
Wall Street News Alert: Breaking News Alert - UCPI! March 27, 2007 NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
WESTON, FL, Mar 27, 2007 (MARKET WIRE via COMTEX) -- Wall Street News Alert's "stocks to watch" this morning are:
Unicorp Inc., (OTCBB: UCPI),
Anadarko Petroleum Corporation (NYSE: APC),
Exxon Mobil Corporation (NYSE: XOM) and
Baker Hughes Incorporated (NYSE: BHI).
Investors should be watching Unicorp Inc., (OTCBB: UCPI) for activity this morning. Yesterday after the markets closed, the company (engaged in the acquisition, development, exploration and production of crude oil and natural gas) issued a press release announcing that operations to complete its South Creole Prospect located in Cameron Parish, Louisiana have been initiated and expects that the well will be perforated within the next several days.
This is expected to be good news! Expectations are for this prospect to double Unicorp's existing revenue. The electric logs indicated approximately 35 feet of pay and the expectations are for this well to come online at approximately 3 Mmcfpd gross gas production.
The South Creole Prospect was drilled to a depth of approximately 11,300 feet targeting the Planulina A formation. Total reserves are estimated to be 2.5 Bcf of natural gas with associated condensate production. Unicorp has a 28.3% before payout working interest and approximately a 21% net revenue interest in the well.
Last Week Unicorp announced results of operations including revenue up over 280% for 2006 and the expectations that revenue for 2007 will be up over 300% versus 2006. Based upon the current projects to which Unicorp is participating, the company is projecting revenue for fiscal 2007 in excess of $4,000,000 and gross profit from oil and gas operations excluding depletion in excess of $3,000,000.
The company had previously provided guidance that gross profit for 2007 would triple based upon its current prospects and reaffirms this projection. Unicorp previously reported it would be profitable from operations excluding non-cash charges during the first quarter of 2007 but now expects to achieve this during the second quarter of 2007.
Unicorp is not just prospecting; this company is generating revenue from oil! It is still anticipated that gross oil production, from the North Laurel Ridge Prospect will be approximately 400 barrels of oil per day. Unicorp has a 21% working interest and an approximate 16% net revenue interest in the well.
Before the news hit the wires, Unicorp's stock closed yesterday at Thirty Five cents a share.
In case you are not familiar with the company:
Unicorp, Inc. is primarily engaged in the acquisition, development, exploration and production of crude oil and natural gas. Its focus is on aggressively acquiring working interests in crude oil and natural gas properties with the intent of exploration and development or by enhancing production through the use of modern development techniques such as horizontal drilling, satellite technology and 3-D seismic. The company's goal is to achieve a high return on its investment by limiting its up-front acquisition costs, by quickly developing its acquisitions and by practicing a sound and smart approach to oil and gas exploration and development.
Anadarko Petroleum Corporation (NYSE: APC) up 2.4% on 7.9 million shares traded. Anadarko Petroleum Corporation's mission is to deliver a competitive and sustainable rate of return to shareholders by exploring for, acquiring and developing oil and natural gas resources vital to the world's health and welfare.
Exxon Mobil Corporation (NYSE: XOM) up 0.5% on 27.5 million shares traded. Exxon Mobil Corporation is an international energy company whose subsidiaries have operations in many countries and territories.
Baker Hughes Incorporated (NYSE: BHI) up 0.4% on 3.2 million shares traded. Baker Hughes is one of the leading providers of drilling, formation evaluation, completion and production products and services to the worldwide oil and gas industry.
US-Touristenbranche sorgt sich um Einwanderungs-Schikanen
Es wird Frühling in New York, und mit den Kirschblüten im Central Park erwacht eine Industrie aus dem Winterschlaf: die Tourismus-Branche. In den nächsten Monaten werden Millionen Menschen kamera-behängt in der Weltstadt am Hudson, bei den Niagara-Fällen, im Grand Canyon und in L.A. einfallen – hoffentlich.
Denn die Zeiten sind vorbei, in denen der Zustrom internationaler Touristen in den USA stetig zunahm. Von einem dramatischen Einbruch unmittelbar nach den Terror-Attacken auf das World Trade Center hat sich die Branche zwar weitgehend erholt. Im vergangenen Jahr wurden US-weit 51,1 Millionen Touristen gezählt und damit etwa so viele wie im Rekord-Jahr 2000. Doch von den einst vom Handelsministerium prognostizierten 60 Millionen ist man weit entfernt.
Darum sorgt sich die „Discover America Partnership“, ein Branchenverband, in dem sich Vertreter zahlreicher Touri-orientierten Unternehmen zur gemeinsamen Lobby-Arbeit zusammengeschlossen haben. Im Gremium sitzen die CEO von Hotelketten und Casinos, von Freizeitparks, Messezentren und Mietwagen-Firmen. Sie alle haben ein Ziel vor Augen: Jedes Jahr mehr internationale Touristen ins Land der unbegrenzten Möglichkeiten zu locken. Doch das wird immer schwieriger.
Dabei ist es gar nicht einmal das politische Umfeld, dass die USA in den letzten Jahren für Besucher unattraktiver gemacht hätte. Republikanische Hardliner hin, Irakkrieg her, Touristen können laut einer groß angelegten Studie über solche Probleme hinwegsehen. Auch eine etwaige Terror-Gefahr nehmen die Besucher in Kauf – was sie abschreckt, ist vielmehr der Terror-Schutz. Der hat nämlich dazu geführt, dass die Einreise am New Yorker und an anderen Flughäfen in den letzten Jahren zu einem wahren Albtraum geworden ist.
39 Prozent der befragten internationalen Touristen erklären, die Einreise in die USA ist die schwierigste überhaupt – angefangen von der Beschaffung des Visums bis hin zu langen Schlangen und unfreundlichen Beamten am Einreise-Schalter. 66 Prozent der Touristen haben Angst, schon wegen eines klitzekleinen Fehlers auf einem Dokument stundenlang festgehalten oder gar zurückgeschickt zu werden.
Nur magere 12 Prozent der Touristen – befragt wurden Reisende aus 16 Ländern von China und Russland über Deutschland und Frankreich bis hin zu Argentinien und Kolumbien – halten den Einreise-Service in die USA für „einladend und freundlich“. Doppelt so viele sprechen sich für die Einreise in ein europäisches Land aus.
Entsprechend hat sich das Reiseverhalten angepasst: Die Zahl britischer Touristen in den USA ist in den letzten sechs Jahren von 4,7 aus 4,2 Millionen gefallen. Aus Japan kamen einst 5 Millionen und heute nur noch 37 Millionen, unter den Franzosen zieht es jährlich 790 000 in die Vereinigten Staaten, wohin einst 1 Million reisten.
Für einen kleinen Ausgleich sorgen steigende Touristenzahlen aus China, Indien, Südkorea und Mexiko – doch macht eben diese Verschiebung der Branche Sorgen. Denn Besucher aus den genannten Ländern geben weniger Geld aus als Europäer und Japaner.
Entsprechend fordert man nun Maßnahmen, den Trend umzukehren. Der Branchenverband denkt an ein Programm für „registrierte Reisende“, die am Flughafen schneller abgewickelt werden könnten. Oder an eine Visum-Bearbeitung von unter dreißig Tagen für Touristen. „Wir wollen auf keinen Fall die Sicherheit mindern“, meint Verbandssprecher Geoff Freeman. „Wir können und müssen aber effizienter arbeiten.“
Lars Halter -
27.03.2007 19:59
Merck & Co. erzielt erneut Erfolg in Vioxx-Prozess
Whitehouse Station, NJ (aktiencheck.de AG) - Der US-Pharmakonzern Merck&Co. Inc. (ISIN US5893311077 (Nachrichten/Aktienkurs)/ WKN 851719) hat am Dienstag einen weiteren Prozesserfolg gegen einen Vioxx-Kläger erzielt.
Demnach hat ein Geschworenengericht in Edwardsville im Bundesstaat Illinois den Pharmakonzern von dem Vorwurf freigesprochen, für den tödlichen Herzinfarkt einer 52-jährigen Frau im Jahr 2003 verantwortlich zu sein. Nach Aussagen der Jury war nicht die Einnahme von Vioxx sondern andere Ursachen wie etwa das starke Übergewicht der Auslöser für den tödlichen Herzinfarkt.
Dieser Prozessgewinn ist der zehnte von bisher 15 Verfahren. Merck&Co. hatte Vioxx im Jahr 2004 vom Markt genommen, nachdem entsprechende Risiken aufgetreten waren.
Die Aktie von Merck&Co. verliert derzeit an der NYSE 0,58 Prozent auf 43,81 Dollar. (27.03.2007/ac/n/a)
Nuvelo, Inc.
27.03.07 20:03 Uhr
4,01 USD
+29,77 % [+0,92]
KGVe:
--
DIVe:
0,00%
https://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=NUVO.NAS&lColors=0x000000&sSym=NUVO.NAS&hcmask=
https://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=NUVO.NAS&lColors=0x000000&sSym=NUVO.NAS&hcmask=
https://isht.comdirect.de/charts/big.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&&lSyms=NUVO.NAS&lColors=0x000000&sSym=NUVO.NAS&hcmask=
Ein WAHNSINNSCHART!!!!!!!!!!!!!!!!
Absolut brutal!
Börse
NASDAQ
Aktuell
4,01 USD
Zeit
27.03.07 20:03
Diff. Vortag
+29,77 %
Tages-Vol.
72,77 Mio.
Gehandelte Stück
23 Mio.
Biotech News: Morning Alert for Nuvelo Inc
Mar 27, 2007 (M2 PRESSWIRE via COMTEX) -- Morning Alert for Nuvelo Inc (NASDAQ: NUVO)
Nuvelo, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for acute cardiovascular and cancer therapy. Its development pipeline includes three acute cardiovascular programs: alfimeprase, a direct-acting thrombolytic that is in Phase III clinical trials for the treatment of thrombotic-related disorders; rNAPc2, an anticoagulant that inhibits the factor VIIa and tissue factor protease complex that is in Phase II clinical development for acute coronary syndromes; and a thrombin inhibiting aptamer for anticoagulation during medical procedures. In addition, the company is developing NU206 for the treatment of chemotherapy/radiation therapy-induced mucositis, as well as rNAPc2 for use as a cancer therapy. Further, the company has two ongoing drug discovery programs focused on the identification of human genes that encode proteins with therapeutic potential. The company has strategic alliances with Amgen, Inc.; Dendreon Corporation; Kirin Brewery Co., Ltd.; Bayer HealthCare AG; and Archemix Corporation. Nuvelo was founded in 1991 and is headquartered in San Carlos, California.
Shares were up 30% after the Food and Drug Administration has granted "fast-track" status to its colon cancer drug candidate.
Electronic Clearing House, Inc.
27.03.07 20:08 Uhr
12,45 USD
-33,10 % [-6,16]
https://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=ECHO.NAS&lColors=0x000000&sSym=ECHO.NAS&hcmask=
https://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=ECHO.NAS&lColors=0x000000&sSym=ECHO.NAS&hcmask=
https://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=ECHO.NAS&lColors=0x000000&sSym=ECHO.NAS&hcmask=
Börse
NASDAQ
Aktuell
12,45 USD
Zeit
27.03.07 20:08
Diff. Vortag
-33,10 %
Tages-Vol.
23,06 Mio.
Gehandelte Stück
2,1 Mio.
ECHO Terminates Intuit Merger Agreement, Cooperates In Federal Online Gambling Probe
Mar 27, 2007 (financialwire.net via COMTEX) -- March 27, 2007 (FinancialWire) Electronic Clearing House Inc. (NASDAQ: ECHO), a provider of electronic payment and transaction processing services, has mutually agreed with Intuit Inc. (NASDAQ: INTU) to terminate the merger agreement entered into by the companies on December 14, 2006. In connection with the termination, ECHO and Intuit agreed to release each other from all claims arising under or related to the terminated merger agreement.
Additionally, ECHO has revealed that it has been cooperating as a witness in a federal investigation relating to its Internet wallet customers that provided services to online gaming web sites. Pursuant to a non-prosecution agreement expected to be executed shortly, the government will assure ECHO that it will not pursue any action against the company. ECHO has in turn agreed to disgorge $2.3 million, which represents management's estimate of the company's profits from processing and collection services provided to its Internet wallet customers since 2001, and to continue cooperating as a witness in that investigation.
The company expects to incur additional legal expenses related to the federal investigation. Earlier in 2007, ECHO ceased all processing and collection services for its remaining Internet wallet customers.
CV Therapeutics, Inc.
27.03.07 20:19 Uhr
8,04 USD
+19,11 % [+1,29]
https://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=CVTX.NAS&lColors=0x000000&sSym=CVTX.NAS&hcmask=
https://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=CVTX.NAS&lColors=0x000000&sSym=CVTX.NAS&hcmask=
https://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=CVTX.NAS&lColors=0x000000&sSym=CVTX.NAS&hcmask=
Börse
NASDAQ
Aktuell
8,04 USD
Zeit
27.03.07 20:19
Diff. Vortag
+19,11 %
Tages-Vol.
96,85 Mio.
Gehandelte Stück
13 Mio.
Von GESTERN:
Biotech News: CV Therapeutics, Inc. is Added to Watch List
Mar 26, 2007 (M2 PRESSWIRE via COMTEX) -- CV Therapeutics is a development-stage company specializing in small-molecule drugs to treat chronic cardiovascular diseases. The firm's FDA-approved Ranexa, licensed from a Roche subsidiary, treats chronic angina for select patients by altering metabolism. Products in development include Tecadenoson, which potentially treats heart arrhythmias, and Regadenoson, which is a potential cardiac imaging agent. The company has decided to end a co-promotion agreement with Solvay Pharmaceuticals, through which it had marketed hypertension drug ACEON, to focus on commercializing Ranexa.
Shares were down 20% on analyst downgrade.
04.04.2007 20:11
Monster Worldwide: Kurseinbruch übertrieben - sagt Broker
Der Aktienkurs von Monster Worldwide (Nachrichten) ist derzeit massiv unter Druck. Die Muttergesellschaft des Online-Jobvermittlers Monster.com hatte heute eine scharfe Umsatzwarnung abgegeben und dafür geringere Einnahmen aus der Internet-Werbung und dem E-Commerce verantwortlich gemacht.
Die Aktie bekommt jetzt aber Rückendeckung vom Brokerhaus Thomas Weisel. Der Job-Titel sei jetzt überverkauft, heißt es. Das Unternehmen sei in der Lage, seine Kosten aggressiv auf das niedrigere Umsatzniveau zu drücken.
Langfristig sollte die Internationalisierungsstrategie des Online-Dienstleisters zu einem robusten Umsatzswachstum führen. Da sich die Margen dabei auch allmählich wieder verbesserten, sollten die Gewinne in den kommenden Quartalen steigen. Thomas Weisel rät daher, die aktuelle Kursschwäche für Schnäppchenkäufe zu nutzen.
Die Aktie fällte dennoch im Moment 13,5% auf 41,97 Dollar.
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&¤cy=&&lSyms=MNST.NAS&lColors=0x000000&sSym=MNST.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&¤cy=&&lSyms=MNST.NAS&lColors=0x000000&sSym=MNST.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&¤cy=&lSyms=MNST.NAS&lColors=0x000000&sSym=MNST.NAS&hcmask=
Biogenerics Limited Provides Company Update
TYLER, Texas, Apr 11, 2007 (PrimeNewswire via COMTEX) -- Biogenerics Limited (Other OTC:BIGN) Board of Directors is pleased to provide its shareholders with the following company update.
James Lancaster, CEO, is pleased to report that, "All previously announced transactions are proceeding and updates on these will be placed on the Company's web site and announced in detail in future press releases."
The WW Oil and Gas Inc. dividend shares have been issued by the Transfer Agency and, in some cases, have already been received by shareholders. Shares that have to clear the Deposit Transfer Corporation to be further credited to brokerage firms may take up to 90 days to complete. Shareholders will receive 1 (one) WW Oil and Gas Inc. common restricted share for every 19 (nineteen) Biogenerics Ltd. shares held as of the January 2, 2007 record date.
Biogenerics is actively continuing its finalization of the Winfield Oil Field transaction. Mr. Lancaster stated, "This transaction is proceeding nicely within the time frame as indicated by the Company's previous press release."
Website: http:/www.bignltd.com
About Biogenerics Limited
Biogenerics is a diversified investment venture capital firm focused on exploiting and distributing domestic oil and gas reserves. Biogenerics also has joint venture activities with Tyche Energy Inc and Hydroslotter Corp.
BUYINS.NET: APNO, EDNE, SWRI, TPLM, WITM, ILKG Have Also Been Added To Naked Short List Today
Apr 11, 2007 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold list:
Alpha Innotech Corporation (OTCBB: APNO),
Eden Energy Corp. (OTCBB: EDNE),
Seawright Holdings (OTCBB: SWRI),
Triangle Petroleum Corporation (OTCBB: TPLM),
Wits Basin Precious Minerals, Inc (OTCBB: WITM),
Interlink Global (OTC: ILKG).
Alpha Innotech Corporation (OTCBB: APNO) engages in the development, manufacture, and marketing of digital imaging and analysis systems for the life science research and drug discovery markets in the United States and internationally. It primarily offers two product lines, macroimaging and microimaging. Macroimaging product line consists of digital imaging systems that are used to detect, archive, and analyze fluorescent, chemiluminescent, and visible signals from biological samples, such as DNA, proteins and bacterial colonies; and other products comprising a multicolor illuminator module for the company's imaging systems; software for anal